A

ANI Pharmaceuticals

Develops, manufactures, markets prescription drugs

Senior Director - Finance, Rare Disease

Corporate Finance & FP&AConfirmed live in the last 24 hours
Full-timePrinceton, NJ, USA

About the Job

Requirements

  • Deep understanding of pharmaceutical and biotech financial operations, particularly within rare or specialty disease markets.
  • Strong strategic thinking, business acumen, and analytical problem-solving capabilities.
  • Proven ability to lead financial planning, forecasting, and business performance management.
  • Ability to translate complex financial data into actionable insights and clear recommendations.
  • Strong command of generally accepted accounting principles, financial planning and analysis methodologies, and product-level profit and loss management.
  • Expertise in financial modeling, return on investment analysis, and scenario-based forecasting.
  • Proficiency in enterprise resource planning systems such as SAP, Oracle, or similar, and advanced Excel or business intelligence tools such as Power BI and Tableau.
  • Strong ethical judgment and commitment to compliance in a regulated industry.
  • A bachelor's degree in Finance, Accounting, Business Administration, or a related field is required.
  • A minimum of 12–15 years of progressive finance experience, including 5+ years in a senior leadership role within the pharmaceutical, biotechnology, or healthcare industry.
  • Demonstrated experience supporting or leading finance for a rare disease, specialty, or high-value therapeutic business.
  • Deep understanding of pharmaceutical pricing, gross-to-net, and commercialization economics.
  • A proven track record of building and leading high-performing finance teams.
  • Strong experience with forecasting, long-range planning, and strategic analysis.
  • Approximately 10–20% travel is required for site visits, leadership meetings, and business reviews.

Responsibilities

  • Serve as the primary financial leader and strategic advisor for the Rare Disease business unit.
  • Develop and execute financial strategies that support the division’s short- and long-term goals, including revenue growth, margin expansion, and portfolio optimization.
  • Partner with senior business leaders to evaluate and prioritize investments, partnerships, and business development opportunities.
  • Provide financial modeling, scenario planning, and risk analysis to support executive decision-making.
  • Lead strategic planning and budgeting processes in alignment with corporate objectives and product lifecycle management.
  • Oversee all financial planning and analysis activities for the Rare Disease business, including forecasts, variance analyses, and financial reporting.
  • Ensure accurate accounting and financial performance tracking for all products within the rare disease portfolio.
  • Develop and monitor key performance indicators to assess business performance and drive accountability.
  • Partner with Commercial and Supply Chain to forecast product demand, pricing, and gross-to-net impacts.
  • Support new product launches and lifecycle management with financial insights and commercialization analytics.
  • Manage the preparation of monthly and quarterly business reviews, providing clear, data-driven recommendations to leadership.
  • Lead the analysis of product profitability, patient access economics, and channel performance.
  • Drive continuous improvement in financial processes, systems, and data integrity across the division.
  • Lead and develop a high-performing team of finance professionals, fostering a culture of accountability, collaboration, and innovation.
  • Collaborate with Corporate Finance, Commercial Operations, R&D, and Supply Chain to ensure financial alignment and transparency.
  • Serve as a trusted advisor to executive leadership, providing strategic insights that balance business opportunity and financial prudence.
  • Represent the Rare Disease business unit in corporate financial planning and governance discussions.
  • Partner with Compliance and Legal to ensure adherence to financial, ethical, and regulatory standards.
  • Evaluate external opportunities, such as licensing, partnerships, and acquisitions, for strategic fit and financial impact.
  • Provide financial leadership for due diligence and integration of new assets or collaborations in the rare disease space.
  • Support investor relations and external communications by providing financial insights and business performance narratives related to the Rare Disease portfolio.
  • Perform other duties as assigned or requested.

Desired Qualifications

  • An MBA or Certified Public Accountant credential is strongly preferred.
  • Excellent leadership, communication, and stakeholder management skills.
  • High attention to detail with the ability to manage multiple priorities in a fast-paced environment.
  • Excellent communication and presentation skills, with experience influencing executive and board-level stakeholders.

About the Company

ANI Pharmaceuticals

Develops, manufactures, markets prescription drugs

ANI Pharmaceuticals develops, manufactures, and markets prescription medications, including generic and branded products, that are FDA-approved. Its medicines are produced in regulated facilities and go through standard safety and efficacy testing to meet patient needs. The company sells these products to pharmacies, hospitals, and healthcare providers, using a portfolio that spans generic drugs and specialty branded therapies. What sets ANI apart is its combination of a diversified product lineup with growth through strategic acquisitions to expand its offerings and market reach, rather than relying on a single product area. Its goal is to provide high-quality medicines to patients while continuously expanding its portfolio and market presence through acquisitions and manufacturing capabilities.

Company size
501-1,000
Company stage
IPO
Headquarters
Baudette, MN
Founded
1996

Recently Posted Jobs

Explore more opportunities at ANI Pharmaceuticals

See more jobs